Compare Novartis AG (NVS) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Toronto-Dominion Bank — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Toronto-Dominion Bank trades at $120.5 (market cap $197.03B). The key difference: Novartis AG is the larger of the two by market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | TD | |
|---|---|---|
Market Cap | $290.25B | $197.03B |
Sector | Health | Financials |
52-Week High | $168.62 | $124.80 |
52-Week Low | $113.50 | $72.55 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | 2.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
